AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
Oct 2, 2015
29821_dirs_2015-10-02_33f1b9cd-d389-449a-bd21-d60f60853aec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-10-01
Reporting Person: MACMILLAN STEPHEN P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-01 | Deferred Stock Units | $ | A | 674.0000 | Acquired | Common Stock (674.0000) | Direct | |
| 2015-10-01 | Stock Option (Right to Buy) | $16.6900 | A | 2151.0000 | Acquired | 2025-10-01 | Common Stock (2151.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Reflects a value of $11,250 divided by the closing price of common stock on the date of grant.
F3: Deferred stock units were granted in lieu of half of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4: Reporting person received half of the cash compensation for the third quarter of 2015 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2016 annual meeting of stockholders.